Hospital Italiano de Buenos Aires
Buenos Aires, C1199ABB, Argentina
NCT Number: NCT04609774
There is little information on the characteristics of airborne severe acute respiratory syndrome coronavirus containing aerosols, their concentration, or their infectivity.The aim was to determine airborne severe acute respiratory syndrome coronavirus transmission, their infectivity in different areas such as patient's room and in medical staff área.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Buenos Aires, C1199ABB, Argentina
The Corona Virus Disease 2019 is rapidly spreading throughout the world. Aerosol is a potential transmission route.
The transmission of severe acute respiratory syndrome coronavirus in humans is thought to be via at least 3 sources: 1) inhalation of liquid droplets produced by and/or 2) close contact with infected persons and 3) contact with surfaces contaminated with severe acute respiratory syndrome coronavirus. There are many respiratory diseases spread by the airborne route such as tuberculosis, measles and chickenpox. Several studies suggested that airborne spread may have played an important role in the transmission of that disease. At present, there is little information on the characteristics of airborne severe acute respiratory syndrome coronavirus containing aerosols, their concentration, or their infectivity.
The aim was to determine airborne severe acute respiratory syndrome coronavirus 2 transmission, their infectivity in in different areas such as patient's room and in medical staff area.
Methods
Cross sectional study of samples from environmental of patient´s room, and medical staff area. Samples will be taken of air using microbial air monitoring systems, and from different surfaces of patient's room and medical staff area, such as computers, mouse and personal protective equipment using cotton swabs. Viral RNA will be determined using Real-Time-Polymerase-Chain Reaction. In positive samples infectiveness will be determined by cell culture under biosecurity conditions.
Statistical analysis will be performed to determine prevalence of positive samples and positive cell culture whit STATA version 15.1.
informed consent will be obtained from all participants
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Severe Acute Respiratory Syndrome CoronaVirus 2 Detection by Real-Time Polymerase Chain Reaction and cell culture
Time frame: 9 moths
Detection of Severe Acute Respiratory Syndrome CoronaVirus 2 RNA by Real Time Polymerase Chain Reaction and cell culture
Hospital Italiano de Buenos Aires
Other
Aerosol Transmission of Severe Acute Respiratory Syndrome Coronavirus: a Dilemma
Acronym: COVID-19
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05119855
COVID-19, Communicable Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT05299359
COVID-19, Coronaviridae Infections
Sumida-ku, Tokyo, Japan
View Trial DetailsNCT04939428
COVID-19, Coronaviridae Infections
Birmingham, Alabama, United States
View Trial DetailsNCT04575597
COVID-19, Coronaviridae Infections
Peoria, Arizona, United States
View Trial Details